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PRESIDENTIAL ADDRESS
From the New England Society for Vascular Surgery
R. Clement Darling Jr, MD, and the evolution of
vascular surgery
Richard P. Cambria, MD, Boston, MassIt is a great honor to serve as the 36th President of the
New England Society of Vascular Surgery, the oldest regional
vascular society in the country. With this honor, of course,
come duty and specifically, the assemblage of a Presidential
Address. I have reviewed Presidential Addresses delivered
before this Society by my teachers and predecessors. The
trends seem clear: decide on fact or philosophy, stick to
something you are at least vaguely familiar with, avoid bore-
dom, and remember that, in Boston, traditionmust be served.
The latter facet is a pleasure, as it has been the great honor of
my professional life to lead the Vascular Division at the Mas-
sachusetts General Hospital founded by Drs Linton and Dar-
ling. I hope there will be a certain satisfaction for our mem-
bership this morning, because my topic is bound to both the
history of our Society and the evolution of vascular surgery
over the past 60 or more years.
I take the lead of my teacher in Dr R. Clement Darling
Jr’s Presidential Address to this Society in 1981, when he
recounted the contribution of his teachers of vascular sur-
gery. Giants like Drs Gross, DeBakey, Cooley, and of
course, Linton, trained him in this new specialty of arterial
reconstructive surgery and set the stage for his numerous
and sentinel contributions to our specialty. Clem Darling
was my first teacher of vascular surgery and my professional
grandfather (Fig 1). I hope to convince you that his con-
tributions to vascular surgery and his stewardship of his
pupils created the foundation for the favorable evolution of
our specialty and our practice that flourishes today.
Although Linton began vascular surgery in New En-
gland at the Massachusetts General Hospital (MGH), it
remained for Dr Darling to both perfect this new specialty
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doi:10.1016/j.jvs.2009.10.112of arterial reconstructive surgery and demonstrate and doc-
ument the safety, efficacy, and long-term results thereof.
Linton was occupied with fundamental technical consider-
ations of this new art of arterial reconstruction. Was end-
to-side preferred to end-to-end? Would homografts suffice
as arterial replacements? Linton, who had assumed the role
of Chief of the Vascular Clinic at the MGH in 1946, was
well at work in the surgical treatment of vascular diseases
when only venous disease and/or portal hypertension were
amenable to direct surgical repair. After the advent of direct
operation for both peripheral occlusive disease by Kunlin in
1949 and abdominal aortic aneurysm (AAA) by DuBois in
1951, Linton introduced these new operations to Boston
in the 1950s. No student of vascular surgery history should
miss the story of these wondrous years, so eloquently
detailed in Dr Bruce Cutler’s Presidential Address to our
Society in 1993, “Robert R. Linton MD—A Legacy of
‘Doing it Right’.”1 It remained for Dr Darling, who joined
Dr Linton in practice in 1960, to provide and document
the evidence for the worth of arterial reconstruction in a
variety of vascular territories. Furthermore, his contribu-
tions, which I will detail shortly, transformed vascular sur-
gery in New England from a series of technical procedures
to correct specific problems to a specialty with comprehen-
sive cognitive, diagnostic, and therapeutic mastery of vas-
cular disease. This was an enabling force for the evolution
of our specialty when transforming ideas like endovascular
therapy subsequently appeared.
No Presidential Address can begin without acknowledg-
ment and thanks to the many that made it possible for me to
be your 36th President. All of you have your traditions, but
please indulge me for a few minutes if I recount the influence
of my father. He was a perfect example of what Tom Brokaw
and Stephen Ambrose termed “the greatest generation” this
country has ever produced. A young teenager in the Depres-
sion, he worked in a pharmacy and had aspirations to go to
pharmaceutical school. Therewas nomoney for that, so like so
many of his generation, he joined the military and ultimately
spent eight and a half years of the prime of his life in the service
of his country.
When I was 26, I was studying to complete my medical
school examinations. When he was 26, he was climbing in
the navigator bombardier’s compartment on a B-25, in the
horror of World War II’s Pacific Theater in 1945. He was
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Bomber Squadrons were all instructed to maintain a 50-
mile airspace berth around Nagasaki. He witnessed the
mushroom cloud, and 2 days later, of course, the GreatWar
was over. What mixture of emotions must have filled him?
The horror of the War in the Pacific and the dawn of the
Nuclear Age, but from a practical standpoint, the antici-
pated joy of finally going home.
Later, when I was about 12 years old, my weekends
were spent working in my father’s family butcher shop. To
give you some perspective, a gallon of gas, a quart of milk,
and a pack of cigarettes each cost 28 cents! My father was
my first teacher of surgery as he taught me the principles of
traction and counter-traction when he taught me how to
cut up a chicken! I have two distinct memories. The first is
the one time I ever asked him, and the only time he ever
talked about, his World War II experiences. He was a
navigator bombardier on a B-25; the words “bombs away”
brought delight to the entire crew, because that meant it
was time to get out of harm’s way. On that one occasion I
asked him, “What did it feel like to drop bombs?” His only
reply was, “I just hope those bombs never killed anybody.”
If one understands the history of the Pacific Theater in
World War II, it will be recognized that this was the
response of a man possessed of a humanism and kindness
that I could only hope to bring to the thousands of patients
Fig 1. R. Clement Darling Jr, MD (1927-99).who have come under my care over the past 30 years. Thesecond memory is my distinct remembrance of the look on
his face the day I graduated medical school. It was clear to
me my father considered this life’s fulfillment, his part of
the American dream. So you can appreciate that I was very
lucky to be born when I was, and of whom I was.
My career at theMGHbegan as a subintern on vascular
surgery in September 1976. When I joined Dr Darling’s
service, I discovered the specialty that seemed to suit me so
well, because the vascular surgeon was the expert in the
diagnosis, clinical decision making, and execution of the
surgical treatment of the patient afflicted with vascular
disease. As I began internship, I was committed to a career
in vascular surgery. Dr Darling gave me an autographed
copy of the Haimovici’s Textbook of Vascular Surgery and
wrote to me after my subinternship that he had “reported
on my good behavior to those who matter around here.”
Thus, my matriculation on the surgical house staff at the
MGH I attribute to Dr Darling, and his retirement from
clinical surgery was the occasion of my appointment to the
faculty at the MGH in 1986.
My teachers in residency were giants in the world of
surgery. To Jerry Austen, who appointed me and who
shepherded my career, and who I still call on for wisdom, I
owe a great deal. World-class surgeons Ron Malt, George
Nardi, Mort Buckley, C.A. Wang, and the great Professor
Hermes Grillo, weremy teachers in those formative years. A
special thanks is in order to my current Chief, Andy War-
shaw, who appointed me Chief of the MGH Vascular
Division 8 years ago. Bill Abbott, 30th President of this
Society, my predecessor as Division Chief, welcomed me
into his laboratory, facilitated my evolution in academic
vascular surgery, yet allowed me as a young faculty member
my own particular mode of growth.
No surgeon can be effective in isolation, and my part-
ners and colleagues in the Division of Vascular and Endo-
vascular Surgery at the MGH are responsible for the fact
that it is so much fun to come to work every day. In
particular, my senior partner, David Brewster, 27th Presi-
dent of this Society, has been a teacher, mentor, and friend
now for 33 years. When one considers the evolution of
vascular surgery, Dr Brewster’s contributions have been
sentinel. As most of you know, he led the charge in transi-
tion to endovascular aneurysm repair (EVAR) for treat-
ment of AAA when he performed the first such procedure
in New England at the MGH in 1994. His Presidential
Address to this Society—just 9 years ago—on the merits of
EVAR profoundly influenced my own thinking towards
this technology.2 Today, some 70% of AAAs treated at
MGH are managed with EVAR. At the other end of the
spectrum, my younger and newest associates, Drs Mark
Conrad and Virendra Patel, have provided me with the
great satisfaction of bringing the next generation of aca-
demic vascular surgeons along.
I am so pleased my wife of 35 years, Chris, is here with us
today. The life of a resident and then surgeon being what it is,
she has shouldered the bulk of the parenting of our five
children and currently, the two dogs, and she never once said
“do you have to make rounds today?” Well, maybe once.
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is the history of vascular surgery, and Dr Darling’s major
contributions to that, we will get to in just a moment. My
hypothesis is that the maturation of vascular surgery into
the modern era, shepherded by R. Clement Darling Jr, was
an enabling force in the evolution of our practice and our
specialty. Dr Darling taught the mastery of the total disease
process afflicting the vascular surgery patient and the abso-
lute insistence that a practicing vascular surgeon should be
totally familiar with the disease process of atherosclerosis,
its pathophysiology, all of the clinical manifestations, and
yes, complications of treatment; this would maintain the
vascular surgeon as the only logical specialist to provide
total vascular patient care. Parenthetically, as noted below,
Linton and Darling were, in fact, innovators in endovascu-
lar as well as traditional vascular surgery.
Clem Darling was born in California but spent most of
his formative years in Southeastern Massachusetts. As a
young boy, he grew up on the Laneway Farm in Taunton.
The farm was owned by a Dr Gamble, who was a Harvard
chemistry professor, and was managed by Clem’s father.
His was a boyhood of hard knocks and hard work, and
despite the Harvard connection at the farm, or perhaps
because of it, by age 18, Clem had joined the U.S. Marine
Corps in the waning days of WorldWar II. He served in the
Far East, one time being hospitalized withmalaria in China.
He wrote to Clem Hiebert, MD, who would subsequently
introduce him for his Presidential Address before this So-
ciety, that his experiences in a military hospital surrounded
by maimed, war-wounded soldiers was the thing that
piqued his interest in medicine and surgery. He was only 18
at the time, and the impact was profound. His own words
were “particularly to see howmutilated one can be and live,
and yet at the same time to see how well one can look and
yet die.”
He was decorated for his work in the Far East and was
honorably discharged as a 1st Lieutenant in the Marine
Corps; this was a facet of his life that was both a source of
great pride for Dr Darling and offered a perspective of life
that I can perhaps simplify as a no-nonsense, get the job
done approach, that would forever influence his profes-
sional career. He was no academic star during his under-
graduate years at Boston University, and he relates that he
was finally accepted at the Boston University Medical
School only the day before classes started! In 1953, how-
ever, he would graduate first in his medical school class and
become the first Boston University graduate to ever be
accepted as an intern at the MGH.
His initial introduction to cardiovascular disease was
during a stint working in pathology with Dr Robert Gross
at the Children’s Hospital. Darling apparently learned the
benefit of a degree of boldness in surgical decision making
from Dr Gross, who performed the first direct aortic re-
placement in Boston for coarctation with arterial ho-
mografts around 1945. Indeed, the very first paper on
Clem’s curriculum vitae was a study of 17 cases of total
anomalus pulmonary venous drainage published in 1957
with Dr Gross as he was finishing residency.3 More than 20years later, at the time of Dr Darling’s presidency, Dr
Robert Gross would acknowledge Clem’s appointment,
making him an honorary member of the New England
Society for Vascular Surgery. Dr Gross, at that point some
85 years old, commented on Dr Darling’s innovation in
terms of noninvasive diagnosis!
In 1958, appointment to the Super Chief Resident was
the aspiration of all MGH surgical residents. However, Dr
Edward Churchill, his Chief, “with a wink in his eye,” said
Dr Darling was “too good technically to be the Chief
Resident,” and appointed George Zuidema to this posi-
tion. This was, in fact, fortuitous, because Churchill called
one Michael DeBakey, facilitating the appointment of Dr
Darling as Chief Resident in Thoracic and Cardiovascular
Surgery under DeBakey in Houston from 1958 to 1960.
This, of course, was the proverbial “golden opportunity,”
because Darling worked directly with DeBakey, Cooley,
and E. Stanley Crawford. who had recently joined
DeBakey’s faculty after completing the Chief Residency at
the MGH in 1955. The era was apocryphal, being the
virtual origin of direct arterial reconstruction, in particular,
for aortic disease. Thereafter, Dr Darling joined Linton in
practice in 1960, and the rest, as they say, is history.
Perhaps a useful outline to detail Dr Darling’s impor-
tant contributions across the spectrum of vascular surgery
can be found in the announcement of the Commemorative
Surgical Grand Rounds that was held in his honor at the
MGH a few months after his death, and as we stand here
this morning, almost exactly a decade ago (Fig 2). Impor-
tant contributions and landmark publications were pro-
Fig 2. Announcement of the Commemorative Grand Rounds
held at Massachusetts General Hospital, October 28, 1999. Dr
Darling’s Fellows and associates detailed the spectrum of his major
contributions to vascular surgery.duced by Dr Darling in aortic aneurysm disease, lower
hniqu
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embolism, renovascular surgery, and the long-term results
after vascular surgical procedures. By 1961, Linton had
reported in no less a prestigious forum than the New
England Journal of Medicine, a series of 150 elective AAA
repairs with a 10% mortality.4 It remained for Darling to
detail the next two decades of aneurysm surgery at the
MGH in the context of his own prodigious experience: he
treated more than 500 elective patients for AAA in the
1970s, with an operative mortality of 1.7%.5 I should like to
remind the younger members of the audience that there
were no Persantine-thallium scans, there were no pulmo-
nary artery catheters, every patient got a tube gastrostomy
with intermittent clamping beginning on the fifth postop-
erative day, and no one cared too much about length of
stay! The secret to these superb results was Darling’s rigid
adherence to Linton’s simple, yet quintessential principle of
vascular surgery: “it must be done right.” Shown in Fig 3,
made from one of Dr Darling’s original manuscripts, is his
advocacy of an interrupted suture technique for the proxi-
mal aortic anastomosis. This is a lesson we continue to
teach our fellows today; namely, in the circumstance of a
bad or fragile aorta, go to the interrupted pledgeted tech-
nique. Although Linton began aortic surgery at the MGH,
Darling perfected it, enabling his pupils with a practice
perspective to subsequently mature both EVAR and com-
plicated central aortic surgery.
Published in Circulation in 1977 was one of Dr Dar-
ling’s most famous and widely quoted contributions to
aortic aneurysm disease. In this autopsy study of nearly 500
patients who died with unrepaired AAAs, 25% died of
rupture. The provocative finding from this study was the
finding of rupture in something other than truly large
aneurysms. In addition, the anatomy of rupture and sur-
vival after symptom onset were carefully detailed, as shown
in the Figure (Fig 4) from his manuscript.6 Thus, the
preponderance of retroperitoneal rupture (being some
80%) and its obvious implications for both the potential of
surgical salvage and certain technical considerations (eg,
venous injury) were clearly established. This report was
cited for some 20 years as the definitive work demonstrat-
Fig 3. Interrupted, pledgetted tecing that small aneurysms can and do rupture, and was forthe world of vascular surgery an important work in justify-
ing an aggressive posture towards even modest-sized aortic
aneurysms.
Although his study was not the first to suggest familial
and genetic factors in certain AAA patients, Dr Darling’s
was the largest series systematically analyzed in this regard.
In an article published 20 years ago in Journal of Vascular
Surgery and with his son, Clem, as first author, Dr Darling
presented prospectively gathered data on more than 500
AAA resections. He established the incidence (15%) of
familial aneurysm, the fact that anatomic extent was no
different vs nonfamilial lesions, and most importantly, the
greatly increased rupture risk for familial aneurysms, espe-
cially in women.7 The hypothesis of this important article
emphasizing the morbid history of aortic aneurysm in
women with familial aneurysm has now been verified in
large prospective and population studies for both thoracic
e for proximal aortic anastomosis.
Fig 4. Schematic of topographic location of ruptured abdominal
aortic aneurysm autopsy study of unrepaired aneurysm.6 Eighty
percent of ruptures occurred into the retroperitoneum and were
correlated with symptom duration. Reprinted with permission.and abdominal aortic aneurysms.8-10
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Dr Darling’s pen. These would review the effect of Fogar-
ty’s catheter on the treatment of arterial embolism,11 this
being a follow-up study to an MGH series initially pub-
lished in 1948,12 a full 15 years before the advent of
catheter embolectomy!13 In a review article for the New
England Journal of Medicine, Darling noted that in the
interval of 1963 to 1969 “approximately 1,200 articles
pertaining to the surgery of peripheral vessels have been pub-
lished” and that his reviewwas “an analysis of progress.”14He
was not the first to describe extra-anatomic bypasses for renal
artery reconstruction, but Darling reported one of the initial
large series in this regard and this topic is the subject of the
very last citation on his curriculum vitaewrittenwith this pupil
and confirming the durability of extra-anatomic renal artery
reconstruction.15
In the realm of lower extremity arterial occlusive dis-
ease, it remained for Dr Darling to carry on and mature the
experience that Linton began by performing the first fem-
oropopliteal vein graft at the MGH in 1950 for a popliteal
aneurysm. By 1961, Linton and Darling were reporting
clinical series of femoropopliteal bypass grafts at the Society
for Vascular Surgery (SVS). The initial direct surgical re-
pairs of aortoiliac and femoropopliteal occlusive disease
were long-segment endarterectomies, often closed with a
venous or Linton patch. Careful and scrupulous follow-up
end results after such procedures eventually indicated that
endarterectomy would yield to bypass grafting both for
aortoiliac inflow disease and superficial femoral artery dis-
ease.
A variety of Dr Darling’s landmark publications would
profoundly influence the practice of vascular surgery in
occlusive disease management for the next several decades.
In a sentinel report before the SVS in 1966, saphenous vein
femoropopliteal bypass grafting was established as the gold
standard for revascularization of infrainguinal occlusive dis-
ease, and life-table analysis of such results was reported for
the first time. Dr Darling gathered nearly 300 such cases
performed by he and Dr Linton and reported a 73% actu-
arial 5-year patency.16 Of interest is that John Mannick,
MD, another Bostonian, also presented data at the same
SVS meeting championing the saphenous vein as the pre-
ferred conduit. However, in discussing Darling’s paper, Dr
E. Stanley Crawford of Houston allowed that 8-mm Da-
cron, in his experience, produced equivalent results. His-
tory has shown the Bostonians to be correct!
In a follow-up study presented to the New England
Surgical Society in 1971, Darling demonstrated the supe-
riority of venous autograft bypass vs endarterectomy for
femoropopliteal occlusive disease in a series of 565 femo-
ropopliteal reconstructions performed from 1955 to 1967
and only including patients with a minimum of 3 years of
follow-up. Endarterectomy would pass into the history
books for the treatment of superficial femoral artery dis-
ease.17
Similarly, DrDarling’s personal experience with aortoiliac
reconstruction established the superiority of aortofemoral
prosthetic bypass grafting—as opposed to endarterectomy—for inflow disease. In a landmark paper and report to the
SVS in 1978 with his new partner, David Brewster, MD, as
first author, they detailed nearly 600 patients treated by Dr
Darling for aortoiliac disease from 1963 to 1977. Superior
procedural morbidity and durability (with the now-often
quoted 5-year patency of 91%) was established for aortob-
ifemoral bypass grafting, and remains the gold standard
more than 30 years later.18 Other surgical nuances such as
discerning different patterns of aortoiliac occlusive disease,
the importance of profunda femoris reconstruction, and
the preference for end-to-end proximal aortic anastomosis
as reported in that article have been surgical dogma in
aortoiliac reconstruction for more than 30 years.
Perhaps less known, but arguably of greater overall
impact in the world of vascular disease management, were
Dr Darling’s contributions in the realm of noninvasive
diagnosis for peripheral arterial occlusive disease. Linton
had assembled a surfeit of pioneers in vascular disease at the
MGHVascular Clinic, originally established as the very first
clinic of its kind in 1928 under Arthur Allen, MD, and
subsequently directed by Robert Linton as of 1946. Linton
charged one Fiorindo Simeone, MD, the fourth President
of the New England Society for Vascular Surgery, with the
establishment of a laboratory dedicated to the study of
peripheral vascular disease in 1946. Jimmy Yao, MD, in his
Presidential Address to the Midwestern Vascular Society in
1986, credited Linton and Simeone with the establishment
of the very first noninvasive vascular laboratory in the
country at the MGH in the late 1940s.19 The laboratory
was subsequently run by John Cranley for 2 years, before
his departure to Cincinnati in 1952, whereupon the labo-
ratory gradually petered out.
A chancemeeting in the late 1960s betweenDrDarling
and Jeffrey K. Raines, then a doctoral candidate in engi-
neering at Massachusetts Institute of Technology, resulted
in many hours of basic laboratory research to perfect what
we know today as the pulse volume recorder. Results with
this technique in some 1000 observations were presented
to the SVS in 1971, and the fundamental concept of
segmental pressures and pulse volume recordings was born
as the cornerstone of peripheral vascular noninvasive diag-
nosis.20 The manuscript, published in 1972 begins “A
quantitative segmental pulse volume recorder (PVR) has
been described which is 1) simple, reliable, and reproduc-
ible, 2) capable of standardization, 3) easily employed by
paramedical personnel, and 4) adaptable to measurements
taken after exercise.” This method for diagnosis of periph-
eral vascular disease would become and remains standard
practice, including its use for intraoperative monitoring of
arterial reconstructions.21
Dr Darling subsequently submitted a proposal to W.
Gerald Austen, MD, then Chief of the Surgical Services, to
establish a clinical laboratory, which was initially housed in
our current fellows’ sleep room adjacent to the Bigelow
Amphitheater. With amusement, Darling related that the
laboratory was “started with a budget of about $12,000,
much of which was spent on removing a toilet and two
wash basins.”
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gery, or the Vascular Fellowship, was something very dear
to Clem Darling’s heart. Taking his lead from Linton, who
apparently trained the very first Vascular Fellow in 1946,1
Dr Darling subsequently trained some 30 Vascular Fellows,
at least 11 of whom went on to run vascular divisions of
their own. Outstanding vascular surgeons with an enviable
record of contribution to and leadership for our specialty
were amongst Dr Darling’s trainees. Among the names on
this list are Cliff Buckley, Tom O’Donnell, Jeb Hallett,
George Hamilton, Jay Robison, Bruce Perler, Patrick
O’Hara, and Bruce Brenner. Dr Darling was no genteel
teacher; rather, he was a demanding, intense surgeon ac-
cepting only of perfection. He might admonish a trainee
with “I don’t care if you do it slow and meticulous, or fast
and sloppy, but do you have to do it slow and sloppy!”
Other important contributions made by Dr Darling
included some of the earliest applications of autotransfu-
sion in aortic surgery; with his then Fellow, Bruce Brenner,
the initial report of this strategy appeared in the literature in
1973.22 Although its popularity waned in these early years
as blood banking came into its own, vascular surgeons
today routinely apply the autotransfusion strategy in open
aortic reconstruction.
Finally, Dr Darling’s interest in the physiology of aortic
cross-clamp application, evident in an often-cited reference
published in 1976 in Circulation,23 eventually led to his
collaboration with a young cardiologist by the name of
Charles Boucher, MD, and the opening of the entire field
of cardiac risk stratification in vascular surgery. Hertzer
had, in 1984, published his important paper on consecutive
coronary arteriography in 1000 vascular surgery patients.24
It remained for Boucher and Darling to demonstrate the
efficacy of physiologic noninvasive coronary assessment
with the first report of the use of the Persantine-thallium
scan in vascular surgery patients, which was published in
1985 in the New England Journal of Medicine.25 This
sentinel report established the evident negative predictive
value of physiologic testing with respect to postoperative
cardiac complications and offered a logical alternative to
rampant coronary angiography. In the subsequent 25 years,
literally thousands of studies would be published on this
topic; soon a review of the current status of cardiac risk
stratification will appear in this journal.
Aside from his work in the clinical management of vascu-
lar disease, Clem Darling was an integral and founding mem-
ber of theNewEngland Society for Vascular Surgery. It was at
Darling’s cajoling that the Linton-Darling-Deterling trio
sought to promote the influence of the SVS—founded in
1947—to the regional level to promote specific training
and credentialing in vascular surgery. As shown in Fig 5, an
organizational meeting for a proposed regional vascular
society, in the context of an informal dinner meeting, was
held at the St. Botolph Club in Boston. Those attending
included Allan Callow, Clem Darling, John Davis, Ralph
Deterling, Edward Edwards, Robert Linton, and John
Mannick. The date was September 6, 1973, and the min-
utes closed with a typical example of Clem Darling’s hu-mor, “after some dickering about the bill, the meeting was
adjourned with an agreement to have several other organi-
zational meetings held over the next several months.” The
first meeting of the newly launched Society with Bob
Linton as its first President and Clem Darling as the Secre-
tary/Treasurer was held in 1974, and Clem Darling would
serve as the Society’s Secretary and prime mover for its first
8 years, until he assumed the Presidency in 1980.
But what then of the evolution of vascular surgery?
What perhaps is less well known is how Linton and Darling
began endovascular surgery at the MGH. Endovascular
work, of course, in its early days, meant diagnostic arteriog-
raphy. Aortography was through the translumbar route,
and run-off arteriography was accomplished by the single-
needle femoral puncture technique. Dr Darling did not
initiate diagnostic arteriography at the MGH but was the
first to critically evaluate both the results and complications
of diagnostic arterial catheterization. He was also senior
author on the first report describing the utility of transle-
sional gradients in the diagnosis of aortoiliac disease.26
At the American College of Surgeons Clinical Congress
in 1976, he presented a careful analysis of both puncture
site and systemic complications of arteriograms in more
than 8000 patients (Fig 6). To my knowledge, this was the
initial critical evaluation by vascular surgeons of their own
endovascular procedures. Gradually, surgeons acquiesced
the performance of diagnostic arteriography to their radiology
colleagues beginning in the early 1970s.Only a few years later,
Dr Darling would refer a patient for the initial endovascular
therapeutic procedure performed at the MGH.
Even as Darling’s prodigious practice was flourishing
and the fundamentals of arterial reconstructive surgery
were seemingly well established, an almost obscure event
would change forever the evolution of vascular surgery.
Charles Dotter was born in Boston in 1920, took his
training in radiology at Cornell, and spent the bulk of his
professional career at the University of Oregon, where he
chaired the Department of Radiology for some 20 years.
Given the rapid pace of the march to minimally invasive
therapies that we have witnessed, it is difficult to contem-
plate and perhaps understand the slow initial growth of
endovascular surgery. In a 1964 report of 11 cases pub-
lished in Circulation, Dotter described his technique of
graduated Teflon dilator expansion of even totally occlusive
superficial femoral artery lesions.27 Although the technol-
ogy was crude, the concept of endoluminal therapy was
born. Dotter stated in his sentinel publication:
It seems reasonable to expect that the transluminal tech-
nic (sic) for recanalization will extend the scope of treat-
ment beyond the limits of present day surgery. . . Thus,
however primitive its present state of development, and
though its application has largely been confined to surgi-
cal “cast-offs,” transluminal recanalization has proved to
be an effective alternative to surgical reconstruction.
Again, the year was 1964. Perhaps related to crude
instrumentation and/or Dotter’s seemingly antagonistic
relations with his surgical colleagues, the concept lay dor-
Soci
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rected the concept of endoluminal therapy and also added
the important advance of performing the dilatation hydro-
statically with a balloon catheter. Although Gru˝ntzig rap-
idly gained notoriety for percutaneous transluminal angio-
plasty (PTA) of coronary lesions first reported in 1978,28
he applied and perfected the concept initially in the super-
ficial femoral artery.29 By 1976 a young MGH radiologist,
Arthur Waltman, had visited Gru˝ntzig twice in Switzerland
and subsequently performed the first iliac PTA at theMGH
in 1976 on a patient referred by Dr Darling!
Waltman, still one of our vascular radiologists, pre-
sented the very first report of this technique to the New
England Society for Vascular Surgery at its annual meeting
in 1979.30 At Dr Darling’s Presidential Address at the
annual meeting in 1981, this series had matured, detailing
a 3-year follow-up of the PTA technique with ClemDarling
Fig 5. Original documents relative to the origins of the
first organizational meeting. B, Founding Officers of the
some 37 members, by the initial 1974 meeting.as one of its senior authors.31 Now I don’t mean to implythat DrDarling was an early enthusiast with respect to periph-
eral angioplasty. Indeed, I can certainly recall the sarcastic
humor with whichClem described balloon-angioplasty, char-
acterizing it as “percutaneous intimal disruption or PID”!
The analogy with a certain infectious gynecologic malady
was, of course, entirely intentional.
Yet, Clem Darling began a tradition of referral to our
interventional radiologists to treat selected patients’ occlu-
sive disease with balloon angioplasty. Some 20 years later,
at the 2003 Annual Meeting of this Society, Jim Black,
MD, then one of our Vascular Fellows, presented results of
an aggressive posture with percutaneous endovascular ther-
apy for infrainguinal occlusive disease.32 This occurred in
the context of our newly created comprehensive program
of vascular surgeons performing all their own endovascular
procedures. The unit at the MGH was renamed “The
Division of Vascular and Endovascular Surgery” as of 2002.
England Society for Vascular surgery. A,Minutes of the
ety noted on its initial membership roster, which totaledNewThe discussion of Dr Black’s paper was lively; our sugges-
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of infrainguinal occlusive disease was guffawed a bit, and
the reviewers insisted that the words “paradigm shift” be
deleted from the manuscript title. There is little doubt that
a paradigm shift has indeed occurred in occlusive disease
management.
After his retirement from clinical surgery, Dr Darling
continued to see patients, conduct studies in the genetics of
aneurysm disease, and publish some of his more widely
quoted papers during this time. He acknowledged that the
history of extensive thoracoabdominal aneurysm surgery
was one that had yet to be perfected at the MGH. He
nurtured, supported, and provided the patients for our
initial forays into the successful surgical management of
these extensive lesions. Linton had begun thoracoabdomi-
nal surgery at the MGH as far back as 1970. Yet, the fact of
the matter was that in the years before 1985, elective
resection of these extensive aneurysms was accompanied by
a mortality rate as high as 50%.
Dr Darling speculated to me that we needed a different
approach, and together we studied the work of Dr Craw-
ford. The modern era in the treatment of these lesions in
Boston is best described in the initial paper, which Dr
Darling and I wrote, detailing the simple fact that a better
operation, with shorter cross-clamp times, and less blood
turnover, minimal anticoagulation, and a relative departure
from the classic Lintonian teachings was necessary for the
successful surgical management of these patients.33
Clem Darling was a complex individual. He brought
the same intensity— perhaps even reckless abandon—to his
career in surgery as he did to his service in the Marine
Corps. He would be working on academic projects at 4:00
AM because it would be the only time to avoid interruption.
This same intensity worked to the benefit of his patients and
sometimes to the suffering of his colleagues and trainees.
He did not suffer fools, and he cared little for what we
would refer to today as “political correctness.” His advice
on risk stratification to his patients was sometimes delivered
harshly, refusing to consider offering an operation until the
Fig 6. An original slide from Dr Darling’s collection details dif-
ferent access site complications as a function of access route. Ax,
Axillary artery; LUMB, translumbar.patient lost 40 pounds or admonishing a patient that obe-sity doesn’t come from breathing the air; or the occasion
when making rounds and using a half-full urinal to douse a
patient’s lit cigarette! Imagine my trepidation as a fourth-
year medical student in walking into the operating room of
this lofty Bostonian with the more lofty sounding name of
R. Clement Darling Jr. I was, of course, delighted to find
Dr Darling anything but aloof. He was irascible, irreverent,
and he had a genuine penchant for the politically incorrect;
accordingly, I was immediately attracted to him.
I last spoke with Clem Darling the morning of his
surgery in August 1999. He was to undergo an elective left
colectomy for recurrent diverticulitis. He thanked me for
my visit, and assured me he was not at all worried because
he had a good surgeon and a good anesthesiologist; then,
the circle that brought ClemDarling and I together, would
close in a somewhat ironic but sweet manner. The orderly
who would transport him to the operating room was one
Justin Cambria, my then 19-year-old son working that
summer as an orderly in the operating room. When Clem
saw his name tag, he engaged him fully, filled him with
stories of how proud he was of this pupil, and (while I mean
no disrespect to anyofDrDarling’s other trainees) referred to
me as his “best student, resident and colleague.” Clem Dar-
ling did not survive his colon resection, succumbing a week
after surgery to a cerebral hemorrhage at the age of 71.
Today, Clem Darling would be very pleased with the
evolution of his Vascular Surgery Unit at the MGH; the
complete mastery of all cognitive and technical compo-
nents of treating the vascular patient, and most impor-
tantly, careful analyses and publication of outcomes taught
to the present generation by Dr Darling was/is the en-
abling element in the wonderful evolution of vascular sur-
gery. I can only hope that my stewardship of the division of
Linton and Darling continues the tradition not only of
superb clinical care but also of innovation, academic pro-
ductivity, and the critical evaluation of everything we do. I
also know that Dr Darling would be very proud of the
accomplishments of his son, R. Clement Darling III, MD,
who directs an extremely productive academic vascular unit
in Albany, New York, who has also served as president of a
regional vascular society, and who is a genuine national
force for vascular surgery in his work for the SVS. He is also
my close friend.
I thank you for your kind attention and for your ongo-
ing contributions to the New England Society for Vascular
Surgery.
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